Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples